Manchester
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
26- Orthopaedic Surgery
- 26
Vendor qualification for orthopedic accounts
Orthopedic practices and ambulatory surgery centers typically run new vendors through a formal qualification step before any product reaches an exam room or OR supply closet. That usually means confirming the supplier's registration status, requesting a certificate of analysis for a representative lot, and routing the file to a compliance officer or practice administrator alongside the medical director.
Because Wharton's jelly allografts and exosome products sit in different regulatory categories, many groups ask a supplier to lay out that distinction in writing rather than assume it. Precision Biologics provides that framework alongside each product's documentation so a practice's own counsel can make the determination that applies to its intended use.
- Certificate of analysis for the specific lot
- Donor eligibility summary
- Lot release record
- NPI confirmation for the ordering account
Cold-chain shipping into the Northeast
Cryopreserved formats ship overnight on dry ice in validated containers and are held at -80 degrees Celsius until they leave for a Manchester address. A practice's front desk or surgical scheduling staff is usually the one receiving the package, so confirming who signs for cold-chain freight and how quickly it reaches a -80 freezer is worth settling before the first order ships.
Lyophilized formats are shelf-stable and do not require the same handling, which some groups prefer for off-site storage between scheduled procedures.
Confirming regulatory posture with your own counsel
Precision Biologics does not advise on clinical use, dosing, or procedure selection. Whether a specific intended use for a tissue allograft meets the minimal manipulation and homologous use criteria in 21 CFR 1271.10, or how an exosome product should be classified and sourced, is a determination the practice and its own regulatory counsel need to make.
New Hampshire practices should route that determination through the New Hampshire Board of Medicine's licensing and scope-of-practice guidance as well as internal counsel before adding a new product line.
Opening a verified account
Every order is tied to an NPI number, which Precision Biologics checks against the NPPES registry before an account goes live. Physicians can also request a direct call with our team to walk through product documentation, lot traceability, and how records are maintained on our side - these calls cover paperwork, not clinical guidance.
Pricing is not published and is shared with verified accounts once an NPI is on file.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Does Precision Biologics work with ambulatory surgery centers, not just physician offices, in the Manchester area?+
Yes. Accounts are opened for any licensed physician or clinic with a verifiable NPI, including surgery centers. The verification and documentation process is the same regardless of setting.
What paperwork ships with a tissue allograft or exosome order?+
Each lot includes a certificate of analysis and lot-specific identifiers. Donor eligibility summaries and lot release records are available on request for verified accounts.
Who do we ask about whether a product fits our intended use under 21 CFR 1271.10?+
That determination belongs to your practice and its own regulatory counsel. Precision Biologics can provide product documentation to support that review but does not advise on clinical use or classification.